Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications

Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications

Advances in cancer therapies have improved oncologic outcomes but can potentially expose patients to risk of cardiovascular toxicity. While left ventricular (LV) dysfunction is a well-known cardiotoxicity of cancer therapy. Pulmonary hypertension (PH) and right ventricular (RV) dysfunction are seen...

Full description

Bibliographic Details
Main Authors: Orly Leiva, William Beaty, Steven Soo, Manyoo A. Agarwal, Eric H. Yang
Format: Article
Language:English
Published: IMR Press 2024-03-01
Series:Reviews in Cardiovascular Medicine
Subjects:
cardio-oncology
cardiotoxicity
pulmonary hypertension
right ventricular dysfunction
Online Access:https://www.imrpress.com/journal/RCM/25/3/10.31083/j.rcm2503087

Internet

https://www.imrpress.com/journal/RCM/25/3/10.31083/j.rcm2503087

Similar Items